BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4118903)

  • 1. Cell-mediated immunity to human malignant cells. A brief review and further studies with two gynecologic tumors.
    DiSaia PJ; Sinkovics JG; Rutledge FN; Smith JP
    Am J Obstet Gynecol; 1972 Dec; 114(7):979-89. PubMed ID: 4118903
    [No Abstract]   [Full Text] [Related]  

  • 2. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M; Barlow JJ
    Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immune reaction to two gynecologic malignant tumors.
    DiSala PJ; Rutledge FN; Smith JP; Sinkovics JG
    Cancer; 1971 Nov; 28(5):1129-37. PubMed ID: 5125661
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian tumor-specific antigens.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1974 Aug; 119(7):966-70. PubMed ID: 4135399
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated immunity in patients with ovarian carcinoma.
    Chen SY; Koffler D; Cohen CJ
    Am J Obstet Gynecol; 1973 Feb; 115(4):467-70. PubMed ID: 4346615
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-associated antigens in gynecologic cancer.
    DiSaia PJ
    Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological aspects of gynecological malignancies.
    DiSaia PJ
    J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary.
    Bhattacharya M; Barlow JJ; Chu TM; Piver MS
    Cancer Res; 1974 Apr; 34(4):818-22. PubMed ID: 4205513
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of tumor antigens in gynecologic malignancies.
    Gall SA
    J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 11. [Production of polyclonal antibody against ovarian epithelial carcinoma and its use in tumor localization].
    Hu XF
    Zhonghua Fu Chan Ke Za Zhi; 1988 Jan; 23(1):31-4, 61. PubMed ID: 3383693
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic studies of human serous cystadenocarcinoma of ovary. Demonstration of tumor-associated antigens.
    Bhattacharya M; Barlow JJ
    Cancer; 1973 Mar; 31(3):588-95. PubMed ID: 4632680
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulatory and cellular immune responses to squamous cell carcinoma of the uterine cervix.
    Chiang WT; Wei PY; Alexander ER
    Am J Obstet Gynecol; 1976 Sep; 126(1):116-21. PubMed ID: 786019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for specific tumor cytotoxic antibodies in serum of cervical cancer patients.
    Weintraub I; Klisak I; Lagasse LD; Byfield JE
    Am J Obstet Gynecol; 1973 Aug; 116(7):985-92. PubMed ID: 4124024
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of cell-mediated immunity and blocking factor using a new line of ovarian cancer cells in vitro.
    Pattillo RA; Story MT; Ruckert AC
    Cancer Res; 1979 Apr; 39(4):1185-92. PubMed ID: 421202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence.
    Nelson DS
    Clin Exp Immunol; 1974 Jan; 16(1):53-62. PubMed ID: 4619779
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactivity of polyclonal and two monoclonal antibodies with cell subsets isolated from cystic fluids of ovarian serous neoplasms.
    Harłozińska A; Bar JK; Rabczyński J; Bast RC; Richter R; Cisło M
    Tumori; 1990 Oct; 76(5):505-10. PubMed ID: 1701581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic study of a case of spontaneous regression of metastatic carcinoma of the portio].
    Moggian G; Barboni F; Sabetta C
    Cancro; 1974; 27(3):165-8. PubMed ID: 4465036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of humoral and cellular immunity in the course of ovarian carcinoma].
    Laghi V; Carella G; Burrai I; Sacco F; Margariti PA; Villani L; Benedetti Panici P
    Minerva Ginecol; 1979 Oct; 31(10):737-46. PubMed ID: 317512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.